$GEVO

Agiri Oluwagbemileke Yusuf sold $28K of GEVO

Agiri Oluwagbemileke Yusuf (CFO) sold 18,223 shares of Gevo, Inc. (GEVO) at $1.54 on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Agiri Oluwagbemileke Yusuf
Published Aug 7, 2026, 9:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The disclosure provides incremental information about insider activity but does not introduce new operational or financial guidance for Gevo.

02

Market read

A small, scheduled insider sale is unlikely to change valuation materially, but it can marginally influence short-term sentiment.

03

What to watch

Traders may over-weight small insider sales; without accompanying guidance, financing, or operational updates, the disclosure is mostly sentiment noise.

Relevance 2/10Novelty 3/10Timing: filed after-hours on 2026-08-07, covering a sale dated 2026-08-06

Background

The filing is an SEC Form 4 insider transaction by Gevo’s CFO, reported as an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

GEVO disclosed an officer (CFO Agiri Oluwagbemileke Yusuf) open-market sale of 18,223 shares at $1.5384 on 2026-08-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived unless accompanied by other company-specific news.

Evidence & confidence

Form 4 shows a pre-arranged 10b5-1 plan and a single sale transaction size ($28k) that is typically not material to fundamentals.

Market effects

No clear sector read-through from a small, 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • GEVO

    Gevo, Inc., the company whose insider transaction was reported.

  • Agiri Oluwagbemileke Yusuf

    CFO of Gevo, reporting an open-market sale under a 10b5-1 plan.

Related articles

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gevo_q2x2026-ex991.htm EX-99.1 Document Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, tod

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.

$GEVOMed

Gevo Provides Business Update and Announces Progress on Business Objectives

Gevo, Inc. (NASDAQ: GEVO) reported progress on its 2026 business objectives, aiming to potentially more than double prior estimates for non-GAAP Adjusted EBITDA by unlocking carbon pathways, debottlenecking operations, and cost improvements. It expects CFR credit sales in Q3 2026, targets over $70M in 2026 Section 45Z tax credit monetizations, and is advancing Gevo North Dakota expansion and Project Northstar. Q2 results are due Aug. 6.